Patients with low-grade upper tract urothelial carcinoma who achieved a complete response after receiving treatment with ...

Xencor's clear cell renal cell carcinoma treatment demonstrated evidence of anti-tumor activity in a phase 1 trial. The treatment XmAb819 had an acceptable safety profile that was generally well ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved cemiplimab-rwlc for adjuvant treatment of adults with cutaneous squamous cell carcinoma at ...

Primary bladder mucinous adenocarcinoma (BMA) is an exceedingly rare and aggressive malignancy. We report a case of a 72-year-old male presenting with hematuria and dysuria. Imaging revealed a bladder ...

Libtayo is approved for adjuvant treatment in high-risk CSCC patients post-surgery and radiation, showing significant disease-free survival benefits in the C-POST trial. The C-POST trial excluded ...

Frequency and Impact of Constitutional Mismatch Repair Deficiency in Patients With High-Grade Glioma, a Retrospective Analysis of 7 Years in Pakistan: an IRRDC Study We conducted a retrospective, ...

The Breakthrough Therapy designation, introduced by the NMPA, is a key initiative aimed at accelerating the development and approval of innovative medicines that offer significant clinical benefits.

Appendix cancer, also called appendiceal cancer, is when abnormal cells grow and form a tumor in the appendix. Your appendix is a little pouch-like organ attached to the lower right side of your large ...

Carcinomas are cancers that start in epithelial cells, which line organs, skin, and blood vessels. Carcinoma of unknown primary (CUP) means doctors can detect this cancer, but they cannot identify ...

ABSTRACT: Introduction: Renal mucinous tubular and spindle cell carcinomas are uncommon, distinctive renal tumors accounts for less than one percent of renal cell carcinoma. Because of such a rare and ...

Skin malignancies are the most common cancers in the United States. 1 Typically, skin cancer is categorized as either melanoma or non­melanoma skin cancer, which is also known as keratinocyte ...